Results 1 to 10 of about 500,219 (165)

Feasibility and acceptability of DMPA-SC self-injection in Addis Ababa, Ethiopia: a mixed-methods study [PDF]

Reproductive Health
Background Depot Medroxyprogesterone Acetate (DMPA) in a prefilled auto-disabled subcutaneous injectable contraceptive (Uniject™) can be administered by community health workers and clients.
Aderaw Anteneh, Megan M. Lydon, Katherine M. Anfinson, Fikreselassie Getachew, Erica Felker-Kantor, Tihut Mulugeta, Teferi Teklu, Rahel Demissew, Holly M. Burke   +8 more
doaj   +5 more sources

Lessons from the scale-up of provider-administered and self-injection of DMPA-SC in Nigeria: a landscape assessment [PDF]

BMC Women's Health
Background Nigeria is the seventh-most populous country in the world. Its high fertility rate and unmet need for family planning contribute to the increasing population size.
Adewole A. Adefalu, Tolulope O. Afolaranmi, Ebony Fontenot, Rachel Simon, Miranda Buba, Victor Dafe, Funmilayo Olabode, Mary Ajayi, Olajimi Latunji, Joy M. Dogo   +9 more
doaj   +5 more sources

DMPA-SC Stock: Cross-Site Trends by Facility Type [PDF]

Contraception: X, 2022
To measure trends in the supply of DMPA-SC in public and private health facilities and compare with other prominent modern methods.We used repeated cross-sectional data from service-delivery-point surveys in six settings: Burkina Faso, Democratic Republic of Congo (Kinshasa and Kongo Central), Nigeria (Kano and Lagos), and Uganda, each with 3-5 rounds ...
Funmilola OlaOlorun, Georges Guiella, Philip Anglewicz   +2 more
exaly   +6 more sources

Scale-up of the DMPA-SC in Nigeria: Why policy matters [PDF]

BMC Women's Health, 2022
Background Injectable contraceptives have contributed substantially to Nigeria's rise in modern family planning methods usage. They are one of the most commonly used and preferred means of contraception among women in the country.
Oluwaseun Akinyemi, Nicole Danfakha, Adewole Adefalu, Ebony Easley, Kayode Afolabi, Olajimi Latunji   +5 more
doaj   +4 more sources

Predictors of DMPA-SC Continuation Among Urban Nigerian Women: The Influence of Counseling Quality and Side Effects [PDF]

Contraception, 2018
In 2015, private healthcare providers in Nigeria introduced DMPA-SC (depot medroxyprogesterone acetate administered subcutaneously) into the method mix. We aimed to [1] examine the sociodemographic predictors of continued DMPA-SC use after 3 months, and [2] characterize the additional influences of contraceptive counseling quality and experiences of ...
Yaning Shen, Jenny X Liu, Nadia Diamond-Smith   +2 more
exaly   +10 more sources

Perspectives on DMPA-SC for self-injection among adolescents with unmet need for contraception in Malawi [PDF]

Frontiers in Global Women's Health, 2023
IntroductionMalawi has made progress in expanding access to modern contraceptive methods over the last decade, including the introduction of depot-medroxyprogesterone acetate subcutaneous (DMPA-SC) in 2018.
Gracious Ali, Chelsey Porter Erlank, Frehiwot Birhanu, Melinda Stanley, Jessie Chirwa, Fannie Kachale, Andrews Gunda   +6 more
doaj   +4 more sources

Factors associated with the acceptability of self-injection training by clients receiving DMPA-SC services from community pharmacies and patent and proprietary medicine vendors in Nigeria [PDF]

BMC Women's Health
Background The self-administration of the subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has the potential to empower women and improve contraceptive use. Several studies have demonstrated the acceptability of the provider-administered DMPA-SC,
Toyin O. Akomolafe, Emeka Emmanuel Okafor, Sikiru Baruwa, Osimhen Ubuane, Michael Alagbile, Delafrida Ukaga, Ijeoma Nwankwo, Rodio Diallo   +7 more
doaj   +4 more sources

Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi. [PDF]

PLOS Global Public Health, 2023
Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC.
Chelsey Porter Erlank, Gracious Ali, Frehiwot Birhanu, Melinda Stanley, Jessie Salamba Chirwa, Fannie Kachale, Andrews Gunda   +6 more
doaj   +4 more sources

Understanding clients’ and providers’ perspectives on the implementation of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) for self-injection programming in Nigeria [PDF]

BMJ Global Health
Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is an injectable contraceptive method with a small needle and prefilled syringe system that has been approved for self-injection (SI) by clients. As DMPA-SC for SI programmes are being scaled, employing an implementation science lens is critical to understanding what works.
Elizabeth Omoluabi, Jenny X Liu, Sneha Challa, Madeline Griffith, Ayobambo Jegede, Aminat Tijani, Emily Himes, Ivan Idiodi, Chioma Okoli, Shakede Dimowo   +9 more
doaj   +7 more sources

Setbacks in the road to self-injection: a descriptive study of provider and mystery client reports on the DMPA-SC care-seeking experience in Nigeria [PDF]

Frontiers in Global Women's Health
This mixed-methods study describes perspectives from health providers and simulated clients on initiation and continuation of DMPA-SC for self-injection in Nigeria.
Madeline Griffith, Sneha Challa, Ayobambo Jegede, Ivan Idiodi, Chioma Okoli, Aminat Tijani, Shakede Dimowo, Awawu Grace Nmadu, Elizabeth Omoluabi, Jenny Liu   +9 more
doaj   +4 more sources